secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acutus Medical, Inc. (—)
CIK:        0001522860
Form:       8-K
Filed at:   2024-04-01T23:59:59+00:00
Accession:  0001628280-24-014025
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acutus Medical FY23: continuing ops revenue $7.2M, net loss $0.41 EPS; exits ablation
--------------------------------------------------------------------------------

- Continuing ops revenue $7.2M FY (+136% YoY); Q4 $2.4M (+118% YoY).
- GAAP net loss continuing ops $11.9M, EPS -$0.41; prior year net income $28.8M.
- Discontinued ops loss $69.7M, including $16.4M held-for-sale loss and $21.9M restructuring.
- Cash, equivalents, marketable securities $29.4M at Dec 31, 2023.
- Company shifts focus to Medtronic left-heart access distribution; no further guidance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522860/000162828024014025/0001628280-24-014025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522860/000162828024014025/afib-20240401.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-014025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer